Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Haemophilus influenzae b vaccine

A vaccine against serotype b of the Gram-negative bacterium H. influenzae (Hib). Hib vaccines contain polysaccharide-protein conjugate antigens that produce greater host immune responses than first-generation purified polysaccharide vaccine. These vaccines may differ with regard to use of protein carriers, polysaccharides, diluents, and preservatives.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:Haemophilus b conjugate vaccine
Haemophilus b oligosaccharide conjugate vacccine
Haemophilus influenzae B Polysaccharide Conjugate Vaccine (PRP-OMP)
Haemophilus influenzae B Polysaccharide Conjugate Vaccine (PRP-T)
Hib TITER vaccine
US brand name:ActHIB
HibTITER
PedvaxHIB
NSC code:722399
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search